|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/21 AdaptHealth Corp. 8-K:1,2,9 4/23/21 11:402K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 31K 2: EX-10.1 Material Contract HTML 100K 7: R1 Cover HTML 49K 9: XML IDEA XML File -- Filing Summary XML 11K 6: XML XBRL Instance -- tm2114401d2_8k_htm XML 15K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- ahco-20210423_lab XML 96K 5: EX-101.PRE XBRL Presentations -- ahco-20210423_pre XML 64K 3: EX-101.SCH XBRL Schema -- ahco-20210423 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 25± 33K 11: ZIP XBRL Zipped Folder -- 0001104659-21-057537-xbrl Zip 26K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i April 23, 2021
(Exact name of registrant as specified in its charter)
| i Delaware | i 001-38399 | i 82-3677704 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
|
i 220 West Germantown Pike, i Suite 250 i Plymouth Meeting, i PA |
i 19462 | ||
| (Address of principal executive offices) | (Zip Code) | ||
| ( i 610) i 630-6357 | |||
(Registrant’s telephone number, including area code)
|
|||
| Not Applicable | |||
|
(Former name or former address, if changed since last report.) |
|||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| i ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| i ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| i ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| i ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| i Class A Common Stock, par value $0.0001 per share | i AHCO | i The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. i ¨
Item 1.01 Entry Into A Material Definitive Agreement.
On April 23, 2021, AdaptHealth LLC, a Delaware limited liability company and wholly owned indirect subsidiary of AdaptHealth Corp. (the “Borrower”), entered into that certain First Incremental Facility Amendment (the “Credit Agreement Amendment”) to the Credit Agreement, dated as of January 20, 2021 (as amended, restated, increased, extended, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrower, the guarantors named therein, Regions Bank as administrative agent and collateral agent and the lenders party thereto. The Credit Agreement Amendment (x) added an incremental term loan in the amount of $100,000,000 as a term loan under the Credit Agreement, increasing the aggregate principal amount of the term loans incurred under the Credit Agreement to $800,000,000, and (y) increased the aggregate revolving commitments available under the Credit Agreement from $250,000,000 to $450,000,000, in each case, with terms consistent with the existing loans and commitments, respectively.
The foregoing description of the Credit Agreement Amendment does not purport to be complete and is qualified in its entirety by the full text thereof, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of the Registrant.
The information set forth in Item 1.01 of this report is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| 104 | Cover Page Data File (formatted as inline XBRL document) |
C:
- C: 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| Dated: April 29, 2021 | ||
| AdaptHealth Corp. | ||
| By: | /s/ Jason Clemens | |
| Name: Jason Clemens | ||
| Title: Chief Financial Officer | ||
C:
- 3 -
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/29/21 | |||
| For Period end: | 4/23/21 | |||
| 1/20/21 | DEF 14A | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/27/24 AdaptHealth Corp. 10-K 12/31/23 114:14M Workiva Inc Wde… FA01/FA 2/28/23 AdaptHealth Corp. 10-K 12/31/22 108:17M Workiva Inc Wde… FA01/FA 3/01/22 AdaptHealth Corp. 10-K 12/31/21 111:19M Toppan Merrill Bridge/FA 8/06/21 AdaptHealth Corp. 10-Q 6/30/21 85:12M Toppan Merrill Bridge/FA 8/06/21 AdaptHealth Corp. S-8 8/06/21 4:70K Toppan Merrill/FA 6/29/21 AdaptHealth Corp. S-3 5:327K Toppan Merrill/FA 6/04/21 AdaptHealth Corp. S-8 6/04/21 3:105K Toppan Merrill/FA 5/10/21 AdaptHealth Corp. 10-Q 3/31/21 84:10M Toppan Merrill Bridge/FA 4/30/21 AdaptHealth Corp. 10-K/A 12/31/20 114:17M Toppan Merrill Bridge/FA |